Everest Medicines Management
Management criteria checks 2/4
Everest Medicines' CEO is Rogers Luo, appointed in Sep 2022, has a tenure of 2.17 years. total yearly compensation is CN¥30.72M, comprised of 23.5% salary and 76.5% bonuses, including company stock and options. directly owns 0.3% of the company’s shares, worth €4.56M. The average tenure of the management team and the board of directors is 2.4 years and 3.2 years respectively.
Key information
Rogers Luo
Chief executive officer
CN¥30.7m
Total compensation
| CEO salary percentage | 23.5% |
| CEO tenure | 2.2yrs |
| CEO ownership | 0.3% |
| Management average tenure | 2.4yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥1b |
| Mar 31 2024 | n/a | n/a | -CN¥949m |
| Dec 31 2023 | CN¥31m | CN¥7m | -CN¥844m |
| Sep 30 2023 | n/a | n/a | -CN¥424m |
| Jun 30 2023 | n/a | n/a | -CN¥3m |
| Mar 31 2023 | n/a | n/a | -CN¥125m |
| Dec 31 2022 | CN¥8m | CN¥2m | -CN¥247m |
Compensation vs Market: Rogers's total compensation ($USD4.24M) is above average for companies of similar size in the German market ($USD1.64M).
Compensation vs Earnings: Rogers's compensation has increased whilst the company is unprofitable.
CEO
Rogers Luo (54 yo)
2.2yrs
Tenure
CN¥30,722,000
Compensation
Mr. Yongqing Luo, also known as Rogers, is CEO & Executive Director of Everest Medicines Limited from September 19, 2022. He was President and General Manager of Greater China at Brii Biosciences Limited a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7.3yrs | no data | 0.59% € 8.9m | |
| CEO & Executive Director | 2.2yrs | CN¥30.72m | 0.30% € 4.6m | |
| CFO, President & Executive Director | 6.4yrs | CN¥18.46m | 0.063% € 942.1k | |
| Chief Business Officer | 5.3yrs | no data | no data | |
| Chief Scientific Officer | 3.6yrs | no data | no data | |
| Chief Legal & Compliance Officer | less than a year | no data | no data | |
| Chief Product Officer | less than a year | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Joint Company Secretary | no data | no data | no data | |
| Joint Company Secretary & VP of Corporate Affairs | 2.7yrs | no data | no data |
2.4yrs
Average Tenure
51yo
Average Age
Experienced Management: 6HN's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7.3yrs | no data | 0.59% € 8.9m | |
| CEO & Executive Director | 2.2yrs | CN¥30.72m | 0.30% € 4.6m | |
| CFO, President & Executive Director | 5.9yrs | CN¥18.46m | 0.063% € 942.1k | |
| Independent Non-Executive Director | 4.2yrs | CN¥401.00k | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 4.2yrs | CN¥401.00k | no data | |
| Independent Non-Executive Director | 1.8yrs | CN¥352.00k | no data | |
| Non-Executive Director | less than a year | no data | no data |
3.2yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 6HN's board of directors are considered experienced (3.2 years average tenure).